bpc-157 human studies safety This is the first vote from the FDA's Pharmacy Compounding Advisory Committee on one of 7 peptides up for consideration. While the committee advises through these votes, ultimately the FDA will make BPC-157: A Prohibited Peptide and

After the initial phase, your treatment will depend on whether your vitamin B12 shortage is caused by your food or whether it is resulting in any neurological issues, such as issues with thinking, memory, and behaviour

Common neurological manifestations include: Paraesthesia (pins and needles) in the hands and feet Numbness and altered sensation Difficulty with balance and coordination (ataxia) Memory problems and cognitive impairment Mood changes, including depression and irritability In severe cases, visual disturbances and confusion These neurological features arise from demyelination of peripheral nerves and the spinal cord, a condition known as subacute combined degeneration when it affects the posterior and lateral columns of the spinal cord

$219 Dealing with tiredness or a foggy mind

However, this difference has no clinical significance